Children's Hospital Colorado
Genevieve Moyer, MD

Genevieve Moyer, MD

Assistant Professor

Specialties:
Hematology, Internal Medicine, Oncology
Conditions:
Clotting Disorders, Blood Disorders, Bleeding Disorders
specialties:

Hematology, Internal Medicine, Oncology

conditions:

Clotting Disorders, Blood Disorders, Bleeding Disorders

Meet Genevieve Moyer, MD

I believe strongly in the importance of getting to know each patient as an individual and engaging them in shared decision making. To accomplish this, I strive to ensure that all my patients understand their diagnosis so that they feel empowered in the pursuit of their own health and wellness.

Get to know her background

Medical Education 2011

Saint Louis University School of Medicine

Residency 2014

Saint Louis University School of Medicine

Fellowship 2018

University of Colorado School of Medicine

Golden Key International Honor Society 2018

Golden Key

Clinical Fellowship Award in Hemophilia and Rare Bleeding Disorders 2018

HTRS/Novo Nordisk

Who's Who in Medicine Higher Education 2019

Academic Keys

For Patients:
At the time I entered my hematology/oncology fellowship, I was eager to pursue clinical research in the area of cancer-associated thrombosis. I chose to study the venous thromboembolism characteristics of individuals from our institution who received stem cell transplantation, focusing on differences between cord blood and non-cord blood recipients. I discovered that not only was post-transplant thrombosis a serious problem, but that these patients were also at an extremely high risk of bleeding with anticoagulation. As a result of this endeavor, I have developed a career interest aimed at developing tools to risk stratify complex patients regarding their risk for bleeding and clotting simultaneously. As my career has progressed, I have also discovered a passion for the treatment of women with bleeding disorders which has led to a goal of balancing our knowledge and understanding of bleeding disorders across genders. I continue to pursue the development of novel tools to aid in bleeding and clotting risk stratification while also spending time investigating these knowledge gaps regarding how to best care for women, transgender, and gender non-binary individuals with disorders of hemostasis.
For Referring Providers:

Assistant Professor

PRODWEBSERVER1